The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
The global health burden of infection‐associated cancers in the year 2002
Open accessAbstract
Several infectious agents are considered to be causes of cancer in humans. The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas. The estimated total of infection‐attributable cancer in the year 2002 is 1.9 million cases, or 17.8% of the global cancer burden. The principal agents are the bacterium Helicobacter pylori (5.5% of all cancer), the human papilloma viruses (5.2%), the hepatitis B and C viruses (4.9%), Epstein‐Barr virus (1%), human immunodeficiency virus (HIV) together with the human herpes virus 8 (0.9%). Relatively less important causes of cancer are the schistosomes (0.1%), human T‐cell lymphotropic virus type I (0.03%) and the liver flukes (0.02%). There would be 26.3% fewer cancers in developing countries (1.5 million cases per year) and 7.7% in developed countries (390,000 cases) if these infectious diseases were prevented. The attributable fraction at the specific sites varies from 100% of cervix cancers attributable to the papilloma viruses to a tiny proportion (0.4%) of liver cancers (worldwide) caused by liver flukes. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Self-citationSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.481 · Cited by 2,316
Cited by
Items 101–158 of 158
The global burden of urinary bladder cancer
Parkin, D. M. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/03008880802285032 · Cited by 357
Self-citationInternational Variations in Bladder Cancer Incidence and Mortality
Chavan, S., Bray, F., Lortet-Tieulent, J., Goodman, M., & Jemal, A. (2014) · European Urology · doi:10.1016/j.eururo.2013.10.001 · Cited by 349
Co-occurrence of anaerobic bacteria in colorectal carcinomas
Warren, R. L., Freeman, D. J., Pleasance, S., Watson, P., Moore, R. A., Cochrane, K., Allen-Vercoe, E., & Holt, R. A. (2013) · Microbiome · doi:10.1186/2049-2618-1-16 · Cited by 348
Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos
Sripa, B., Bethony, J. M., Sithithaworn, P., Kaewkes, S., Mairiang, E., Loukas, A., Mulvenna, J., Laha, T., Hotez, P. J., & Brindley, P. J. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2010.07.006 · Cited by 347
Xi, Y., Ge, J., Wang, M., Chen, M., Niu, W., Cheng, W., Xue, Y., Lin, C., & Lei, B. (2020) · ACS Nano · doi:10.1021/acsnano.9b07173 · Cited by 346
Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases
Rouhani, P., Fletcher, C. D. M., Devesa, S. S., & Toro, J. R. (2008) · Cancer · doi:10.1002/cncr.23571 · Cited by 342
The role of chalcones in suppression of NF-κB-mediated inflammation and cancer
Yadav, V. R., Prasad, S., Sung, B., & Aggarwal, B. B. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.006 · Cited by 339
The Yin and Yang of Toll-like receptors in cancer
Pradere, J.-P., Dapito, D. H., & Schwabe, R. F. (2014) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 331
Quadrivalent Human Papillomavirus Vaccine
Gellin, B., Modlin, J. F., Barr, E., & Tamms, G. (2007) · Clinical Infectious Diseases · doi:10.1086/520654 · Cited by 330
Hepatitis B and hepatocellular carcinoma #
Di Bisceglie, A. M. (2009) · Hepatology · doi:10.1002/hep.22962 · Cited by 321
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
Brothers, H. M., Gosztyla, M. L., & Robinson, S. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00118 · Cited by 314
Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
Hadrup, S., Donia, M., & thor Straten, P. (2013) · Cancer Microenvironment · doi:10.1007/s12307-012-0127-6 · Cited by 310
Human papillomavirus infection: Epidemiology and pathophysiology
Steben, M., & Duarte-Franco, E. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.067 · Cited by 307
The Human Microbiome and Cancer
Rajagopala, S. V., Vashee, S., Oldfield, L. M., Suzuki, Y., Venter, J. C., Telenti, A., & Nelson, K. E. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0249 · Cited by 303
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
HIV infection and the risk of cancers with and without a known infectious cause
Silverberg, M. J., Chao, C., Leyden, W. A., Xu, L., Tang, B., Horberg, M. A., Klein, D., Quesenberry, C. P., Towner, W. J., & Abrams, D. I. (2009) · AIDS · doi:10.1097/qad.0b013e3283319184 · Cited by 299
Takahashi-Kanemitsu, A., Knight, C. T., & Hatakeyama, M. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0339-5 · Cited by 299
Paclitaxel: Application in Modern Oncology and Nanomedicine‐Based Cancer Therapy
Sharifi-Rad, J., Quispe, C., Patra, J. K., Singh, Y. D., Panda, M. K., Das, G., Adetunji, C. O., Michael, O. S., Sytar, O., Polito, L., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3687700 · Cited by 298
Understanding and learning from the success of prophylactic human papillomavirus vaccines
Schiller, J. T., & Lowy, D. R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2872 · Cited by 293
Parkin, D. M., Bray, F., Ferlay, J., & Jemal, A. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0281 · Cited by 291
Self-citationMuro, K., Lordick, F., Tsushima, T., Pentheroudakis, G., Baba, E., Lu, Z., Cho, B. C., Nor, I. M., Ng, M., Chen, L. T., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdy498 · Cited by 289
Chen, W., Xia, C., Zheng, R., Zhou, M., Lin, C., Zeng, H., Zhang, S., Wang, L., Yang, Z., Sun, K., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30488-1 · Cited by 288
How will HPV vaccines affect cervical cancer?
Roden, R., & Wu, T.-C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1973 · Cited by 283
Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
Baecker, A., Liu, X., La Vecchia, C., & Zhang, Z.-F. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000428 · Cited by 275
Cabrera, R. (2012) · Hepatic Medicine: Evidence and Research · doi:10.2147/hmer.s16316 · Cited by 274
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Jit, M., Choi, Y. H., & Edmunds, W. J. (2008) · BMJ · doi:10.1136/bmj.a769 · Cited by 273
Oxidative stress in ulcerative colitis-associated carcinogenesis
Roessner, A., Kuester, D., Malfertheiner, P., & Schneider-Stock, R. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.04.011 · Cited by 271
Cancer transcriptome profiling at the juncture of clinical translation
Cieślik, M., & Chinnaiyan, A. M. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.96 · Cited by 269
Applying What We Know to Accelerate Cancer Prevention
Colditz, G. A., Wolin, K. Y., & Gehlert, S. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003218 · Cited by 268
Helicobacter pylori and gastric adenocarcinoma
Herrera, V., & Parsonnet, J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03031.x · Cited by 266
HATAKEYAMA, M. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.013 · Cited by 261
Mira-Pascual, L., Cabrera-Rubio, R., Ocon, S., Costales, P., Parra, A., Suarez, A., Moris, F., Rodrigo, L., Mira, A., & Collado, M. C. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0963-x · Cited by 262
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
Infections and cancer: Established associations and new hypotheses
de Martel, C., & Franceschi, S. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.021 · Cited by 258
Greenberg, E. R., Anderson, G. L., Morgan, D. R., Torres, J., Chey, W. D., Bravo, L. E., Dominguez, R. L., Ferreccio, C., Herrero, R., Lazcano-Ponce, E. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60825-8 · Cited by 257
Interferons and Their Stimulated Genes in the Tumor Microenvironment
Cheon, H., Borden, E. C., & Stark, G. R. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.002 · Cited by 255
Arvey, A., Tempera, I., Tsai, K., Chen, H.-S., Tikhmyanova, N., Klichinsky, M., Leslie, C., & Lieberman, P. M. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.008 · Cited by 255
Gut microbiota, inflammation and colorectal cancer
Sun, J., & Kato, I. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.03.004 · Cited by 257
Ikeda, N., Inoue, M., Iso, H., Ikeda, S., Satoh, T., Noda, M., Mizoue, T., Imano, H., Saito, E., Katanoda, K., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001160 · Cited by 240
Baker, M. G., Barnard, L. T., Kvalsvig, A., Verrall, A., Zhang, J., Keall, M., Wilson, N., Wall, T., & Howden-Chapman, P. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61780-7 · Cited by 199
Smout, M. J., Laha, T., Mulvenna, J., Sripa, B., Suttiprapa, S., Jones, A., Brindley, P. J., & Loukas, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000611 · Cited by 187
Environmental Influences on the Human Microbiome and Implications for Noncommunicable Disease
Ahn, J., & Hayes, R. B. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-012420-105020 · Cited by 186
Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients
Li, Y.-Y., Ge, Q.-X., Cao, J., Zhou, Y.-J., Du, Y.-L., Shen, B., Wan, Y.-J. Y., & Nie, Y.-Q. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3227 · Cited by 175
Tateishi, R., Okanoue, T., Fujiwara, N., Okita, K., Kiyosawa, K., Omata, M., Kumada, H., Hayashi, N., & Koike, K. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0973-8 · Cited by 170
Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases
Trottier, H., & Burchell, A. N. (2009) · Public Health Genomics · doi:10.1159/000214920 · Cited by 156
Cancer in Africa 2018: The role of infections
Parkin, D. M., Hämmerl, L., Ferlay, J., & Kantelhardt, E. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32538 · Cited by 130
Self-citationMechanisms linking pathogens-associated inflammation and cancer
Porta, C., Riboldi, E., & Sica, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.012 · Cited by 119
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Feller, S., Teucher, B., Kaaks, R., Boeing, H., & Vigl, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073462 · Cited by 96
Huang, Y.-F., Chen, Y.-J., Fan, T.-C., Chang, N.-C., Chen, Y.-J., Midha, M. K., Chen, T.-H., Yang, H.-H., Wang, Y.-T., Yu, A. L., et al. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0329-y · Cited by 72
Hepatitis B control by 2012 in the WHO Western Pacific Region:
Rani, M. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.059220 · Cited by 61
Borozan, I., Zaidi, S. H., Harrison, T. A., Phipps, A. I., Zheng, J., Lee, S., Trinh, Q. M., Steinfelder, R. S., Adams, J., Banbury, B. L., et al. (2022) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0463 · Cited by 57
Zhang, C., Zhang, C.-D., Ma, M.-H., & Dai, D.-Q. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i11.1206 · Cited by 40
Gul, S., Murad, S., & Javed, A. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.02.018 · Cited by 42
Soto, D. R., Barton, C., Munger, K., & McLaughlin-Drubin, M. E. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006661 · Cited by 39
Comorbidity of mental and physical disorders
(2014) · Key Issues in Mental Health · doi:10.1159/isbn.978-3-318-02604-7 · Cited by 37
Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations
Husein, N., & Chetty, A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.016 · Cited by 15
Guo, H., Yang, J., Liu, S., Qin, T., Zhao, Q., Hou, X., & Ren, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.1957645 · Cited by 7
Metadata
- Authors
- Parkin, D. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-01-10
- Volume
- 118
- Issue
- 12
- Pages
- 3030-3044
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2140481064
- Cited by
- 2,932
- References
- 108
- FWCI
- 56.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.